Literature DB >> 22584823

Bifunctional polyethersulfone hollow fiber with a porous, single-layer skin for use as a bioartificial liver bioreactor.

Shichang Zhang1, Tao Liu, Li Chen, Mingliang Ren, Bo Zhang, Zhengguo Wang, Yingjie Wang.   

Abstract

A bioartificial liver bioreactor requires a bifunctional hollow fiber that is hemocompatible on one side and cytocompatible on the other side. In this study, we developed a single-layer skin polyethersulfone (PES) hollow fiber with smooth inner surface and rough/porous outer surface for an artificial liver bioreactor. The hemocompatibility of the inner surface was evaluated by hemolysis, complement activation and clotting time. The cytocompatibility of the outer surface with HepG2 cells was examined by morphology, proliferation and liver-specific functions. The inner surface of the PES hollow fiber exhibited lower hemolysis and complement activation than cellulose acetate (CA) hollow fiber and a prolonged blood coagulation time. HepG2 cells readily adhered to the outer surfaces of the PES hollow fibers, and proliferated to form multicellular aggregates with time. Furthermore, HepG2 cells cultured on the outer surface of the PES hollow fiber exhibited higher proliferation ability and liver-specific functions than those grown on the CA hollow fiber. These results suggest that the single-layer skin PES hollow fiber is a bifunctional hollow fiber with good hemocompatibility on the inner side and cytocompatibility on the outer side. Thus, porous and single-layer skin PES hollow fibers may have potential as materials for an artificial liver bioreactor.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22584823     DOI: 10.1007/s10856-012-4673-8

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  38 in total

1.  Growth of human cells on a non-woven silk fibroin net: a potential for use in tissue engineering.

Authors:  Ronald E Unger; Michael Wolf; Kirsten Peters; Antonella Motta; Claudio Migliaresi; C James Kirkpatrick
Journal:  Biomaterials       Date:  2004-03       Impact factor: 12.479

2.  Biocompatibility of modified polyethersulfone membranes by blending an amphiphilic triblock co-polymer of poly(vinyl pyrrolidone)-b-poly(methyl methacrylate)-b-poly(vinyl pyrrolidone).

Authors:  Fen Ran; Shengqiang Nie; Weifeng Zhao; Jie Li; Baihai Su; Shudong Sun; Changsheng Zhao
Journal:  Acta Biomater       Date:  2011-05-27       Impact factor: 8.947

3.  An organic-inorganic hybrid scaffold for the culture of HepG2 cells in a bioreactor.

Authors:  Ken Kataoka; Yoshitaka Nagao; Takamasa Nukui; Ichiro Akiyama; Kanji Tsuru; Satoshi Hayakawa; Akiyoshi Osaka; Nam-ho Huh
Journal:  Biomaterials       Date:  2005-05       Impact factor: 12.479

4.  Biotransformation and liver-specific functions of human hepatocytes in culture on RGD-immobilized plasma-processed membranes.

Authors:  Loredana De Bartolo; Sabrina Morelli; Linda C Lopez; Lidietta Giorno; Carla Campana; Simona Salerno; Maria Rende; Pietro Favia; Loredana Detomaso; Roberto Gristina; Riccardo d'Agostino; Enrico Drioli
Journal:  Biomaterials       Date:  2005-07       Impact factor: 12.479

Review 5.  A bioartificial liver--state of the art.

Authors:  Alastair J Strain; James M Neuberger
Journal:  Science       Date:  2002-02-08       Impact factor: 47.728

6.  Vascularization and gene regulation of human endothelial cells growing on porous polyethersulfone (PES) hollow fiber membranes.

Authors:  Ronald E Unger; Kirsten Peters; Quan Huang; Andreas Funk; Dieter Paul; C J Kirkpatrick
Journal:  Biomaterials       Date:  2005-06       Impact factor: 12.479

7.  Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure.

Authors:  Achilles A Demetriou; Robert S Brown; Ronald W Busuttil; Jeffrey Fair; Brendan M McGuire; Philip Rosenthal; Jan Schulte Am Esch; Jan Lerut; Scott L Nyberg; Mauro Salizzoni; Elizabeth A Fagan; Bernard de Hemptinne; Christoph E Broelsch; Maurizio Muraca; Joan Manuel Salmeron; John M Rabkin; Herold J Metselaar; Daniel Pratt; Manuel De La Mata; Lawrence P McChesney; Gregory T Everson; Philip T Lavin; Anthony C Stevens; Zorina Pitkin; Barry A Solomon
Journal:  Ann Surg       Date:  2004-05       Impact factor: 12.969

Review 8.  Role of liver transplantation in acute liver failure.

Authors:  Iris W Liou; Anne M Larson
Journal:  Semin Liver Dis       Date:  2008-05       Impact factor: 6.115

9.  Human hepatocyte functions in a crossed hollow fiber membrane bioreactor.

Authors:  Loredana De Bartolo; Simona Salerno; Efrem Curcio; Antonella Piscioneri; Maria Rende; Sabrina Morelli; Franco Tasselli; Augustinus Bader; Enrico Drioli
Journal:  Biomaterials       Date:  2009-01-31       Impact factor: 12.479

10.  BSA-modified polyethersulfone membrane: preparation, characterization and biocompatibility.

Authors:  Zongbin Liu; Xiaopei Deng; Meng Wang; Jingxia Chen; Aimin Zhang; Zhongwei Gu; Changsheng Zhao
Journal:  J Biomater Sci Polym Ed       Date:  2009       Impact factor: 3.517

View more
  4 in total

1.  Functional polyethersulfone particles for the removal of bilirubin.

Authors:  Xin Jiang; Tao Xiang; Yi Xie; Rui Wang; Weifeng Zhao; Shudong Sun; Chang-Sheng Zhao
Journal:  J Mater Sci Mater Med       Date:  2015-12-24       Impact factor: 3.896

2.  Lactobionic acid-functionalized polyethersulfone hollow fiber membranes promote HepG2 attachment and function.

Authors:  Surendra Kumar Verma; Akshay Modi; Ashwin Dravid; Jayesh Bellare
Journal:  RSC Adv       Date:  2018-08-14       Impact factor: 4.036

3.  Integration of single-layer skin hollow fibers and scaffolds develops a three-dimensional hybrid bioreactor for bioartificial livers.

Authors:  Shichang Zhang; Li Chen; Tao Liu; Zhengguo Wang; Yingjie Wang
Journal:  J Mater Sci Mater Med       Date:  2013-08-21       Impact factor: 3.896

4.  The "artificial artery" as in vitro perfusion model.

Authors:  Doreen Janke; Joachim Jankowski; Marieke Rüth; Ivo Buschmann; Horst-Dieter Lemke; Dorit Jacobi; Petra Knaus; Ernst Spindler; Walter Zidek; Kerstin Lehmann; Vera Jankowski
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.